16-79594275-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005360.5(MAF):c.*185G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.915 in 614,508 control chromosomes in the GnomAD database, including 258,308 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.88 ( 58873 hom., cov: 31)
Exomes 𝑓: 0.93 ( 199435 hom. )
Consequence
MAF
NM_005360.5 3_prime_UTR
NM_005360.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0400
Publications
6 publications found
Genes affected
MAF (HGNC:6776): (MAF bZIP transcription factor) The protein encoded by this gene is a DNA-binding, leucine zipper-containing transcription factor that acts as a homodimer or as a heterodimer. Depending on the binding site and binding partner, the encoded protein can be a transcriptional activator or repressor. This protein plays a role in the regulation of several cellular processes, including embryonic lens fiber cell development, increased T-cell susceptibility to apoptosis, and chondrocyte terminal differentiation. Defects in this gene are a cause of juvenile-onset pulverulent cataract as well as congenital cerulean cataract 4 (CCA4). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
MAF Gene-Disease associations (from GenCC):
- Ayme-Gripp syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- cataract 21 multiple typesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
- cataract - microcornea syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cerulean cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulverulent cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fine-Lubinsky syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-79594275-C-G is Benign according to our data. Variant chr16-79594275-C-G is described in ClinVar as [Benign]. Clinvar id is 1281348.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.972 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAF | ENST00000326043.5 | c.*185G>C | 3_prime_UTR_variant | Exon 2 of 2 | 1 | NM_005360.5 | ENSP00000327048.4 | |||
MAF | ENST00000569649.1 | c.1118+4510G>C | intron_variant | Intron 1 of 1 | 5 | ENSP00000455097.1 | ||||
MAF | ENST00000393350.1 | c.*4506G>C | downstream_gene_variant | 6 | ENSP00000377019.1 |
Frequencies
GnomAD3 genomes AF: 0.876 AC: 133080AN: 151954Hom.: 58847 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
133080
AN:
151954
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.928 AC: 429027AN: 462436Hom.: 199435 Cov.: 5 AF XY: 0.930 AC XY: 228287AN XY: 245578 show subpopulations
GnomAD4 exome
AF:
AC:
429027
AN:
462436
Hom.:
Cov.:
5
AF XY:
AC XY:
228287
AN XY:
245578
show subpopulations
African (AFR)
AF:
AC:
9457
AN:
12820
American (AMR)
AF:
AC:
22028
AN:
22900
Ashkenazi Jewish (ASJ)
AF:
AC:
13954
AN:
14532
East Asian (EAS)
AF:
AC:
29766
AN:
29900
South Asian (SAS)
AF:
AC:
43261
AN:
45816
European-Finnish (FIN)
AF:
AC:
23616
AN:
26318
Middle Eastern (MID)
AF:
AC:
1875
AN:
1976
European-Non Finnish (NFE)
AF:
AC:
260882
AN:
282002
Other (OTH)
AF:
AC:
24188
AN:
26172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1501
3003
4504
6006
7507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.876 AC: 133156AN: 152072Hom.: 58873 Cov.: 31 AF XY: 0.879 AC XY: 65343AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
133156
AN:
152072
Hom.:
Cov.:
31
AF XY:
AC XY:
65343
AN XY:
74326
show subpopulations
African (AFR)
AF:
AC:
30483
AN:
41410
American (AMR)
AF:
AC:
14481
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
3347
AN:
3472
East Asian (EAS)
AF:
AC:
5151
AN:
5180
South Asian (SAS)
AF:
AC:
4544
AN:
4804
European-Finnish (FIN)
AF:
AC:
9493
AN:
10582
Middle Eastern (MID)
AF:
AC:
278
AN:
294
European-Non Finnish (NFE)
AF:
AC:
62623
AN:
68008
Other (OTH)
AF:
AC:
1902
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
784
1568
2352
3136
3920
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3265
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.